Skip to content

Karyopharm Therapeutics Inc.

KPTIQ· UnspecifiedCore metricsCIK 1503802

Pharmaceutical preparations552 peers

Filings
1,036
Raw facts
12,379
Metric values
3,752
$33.43M
Q2 2026+0.6% FY25 yoy
-$67.02M
Q2 2026N/M FY25 yoy
-$22.53M
Q2 2026N/M FY25 yoy
-$75.37M
FY 2025derivedN/M FY25 yoy
-$2.32
Q2 2026N/M FY25 yoy
$54.98M
Q2 2026−3.1% FY25 yoy

Financials

Revenue

$146.07MFY 2025
$209.82M0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$146,067,000reported
FY 20242024-12-31$145,237,000reported
FY 20232023-12-31$146,033,000reported
FY 20222022-12-31$157,074,000reported
FY 20212021-12-31$209,819,000reported
FY 20202020-12-31$108,085,000reported
FY 20192019-12-31$40,893,000reported
FY 20182018-12-31$30,336,000reported
FY 20172017-12-31$1,605,000reported
FY 20162016-12-31$154,000reported
FY 20152015-12-31$250,000reported
FY 20142014-12-31$229,000reported

Segments

Products
Revenue by Products, FY2018 to FY2025FY2018License and Other Revenue · FY2018 · $30.34MFY2019Product · FY2019 · $30.54MLicense and Other Revenue · FY2019 · $10.35MFY2020Product · FY2020 · $76.21MLicense and Other Revenue · FY2020 · $31.88MFY2021Product · FY2021 · $98.44MLicense and Other Revenue · FY2021 · $111.38MFY2022Product · FY2022 · $120.45MLicense and Other Revenue · FY2022 · $36.63MFY2023Product · FY2023 · $112.01MLicense and Other Revenue · FY2023 · $34.02MFY2024Product · FY2024 · $112.81MLicense and Other Revenue · FY2024 · $32.43MFY2025Product · FY2025 · $114.86MLicense and Other Revenue · FY2025 · $31.21M
LineFY2025ShareChange
Product$114.86M79%+1.8%
License and Other Revenue$31.21M21%−3.8%
Total$146.07M

From the 10-K filed Feb 13, 2026KPTIQ

Pharmaceutical preparations

Karyopharm Therapeutics Inc. is the 97th largest of the 553 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR